Determination of RAS Mutation Status in Liquid Biopsies in Subjects With RAS Wild-type.PERSEIDA Study
Condition(s):RAS Wild Type mCRCLast Updated:January 11, 2023Completed
Hide Studies Not Open or Pending
Condition(s):RAS Wild Type mCRCLast Updated:January 11, 2023Completed
Condition(s):RAS Peptide Profile in Healthy VolunteersLast Updated:May 13, 2013Completed
Condition(s):Colorectal Cancer; Drug Resistance; Mass Spectrometry; RAS-RAF Pathway DeregulationLast Updated:January 17, 2018Unknown status
Condition(s):SuicideLast Updated:July 31, 2018Completed
Condition(s):Soft Tissue and Bone Tumor; Head and Neck Cancer; SarcomaLast Updated:May 30, 2018Unknown status
Condition(s):Parkinson’s DiseaseLast Updated:October 4, 2012Terminated
Condition(s):Primary Immune Thrombocytopenia (ITP)Last Updated:February 26, 2024Recruiting
Condition(s):Sickle Cell DiseaseLast Updated:June 18, 2015Completed
Condition(s):History of Cardiovascular Disease Treated With RAS Blockers and With SARS-CoV-2 InfectionLast Updated:April 9, 2021Terminated
Condition(s):Parkinson DiseaseLast Updated:August 4, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.